Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRaG 6.0 in Advanced NSCLC and Breast Cancer
NCT05603013Phase 2Unknown
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Oct 2022
- Primary completion
- Jan 2024
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine, sargramostim, aldesleukin in non-small cell lung cancer (NSCLC), breast cancer, sponsored by The Second Affiliated Hospital of Soochow University. Status: unknown.
02
Drugs
vinorelbinesargramostimaldesleukin
03
Conditions
non-small cell lung cancer (NSCLC)breast cancer
Beyond the preview
Go deeper on NCT05603013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05603013.